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Objective: To evaluate the positive predictive value (PPV) of a diagnosis of heart failure (HF) 
in the Danish National Registry of Patients (NRP) among patients admitted to a University 
Hospital cardiac care unit, and to evaluate the impact of misdiagnosing HF.
Design: The NRP was used to identify patients with heart failure from July 1, 2005 to June 
30, 2007. Heart failure was defined in accordance with European Society of Cardiology (ESC) 
guidelines. The recorded diagnoses from the NRP were compared with clinical data from the 
medical records.
Results: We identified 758 patients with a diagnosis of heart failure in the NRP. The PPV of a 
heart failure discharge diagnosis was 84.0% (95% confidence interval: 81.2–86.6). Patients with 
a discharge diagnosis of HF in the NRP without fulfilling the ESC criteria for HF had a better 
survival rate, a lower rate of rehospitalization, none were followed in the outpatient clinic, and 
they had a lower consumption of anticongestive medicine after discharge.
Conclusion: We found a relatively high PPV of the HF diagnosis in the NRP, and the NRP 
can therefore be a valuable tool for identification of patients with HF. However, using the NRP 
alone will not give a true picture of the cost and total burden of the disease.
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Introduction
Heart failure (HF) is a growing public health problem. The prevalence of HF is 
2%–3% in western countries and rises sharply among 70- to 80-year-old people with 
a prevalence of about 10%–20%.1 HF is the cause of 5% of acute hospital admissions 
and is present among 10% of patients in hospital beds in the United Kingdom (UK).1 
It has been estimated that HF accounts for more than 2% of national expenditure on 
health in the UK.1
The diagnosis of HF can be difficult to define. It might be easy to diagnose HF in 
its moderate or severe form where the patient has characteristic symptoms and signs of 
HF with echocardiographic evidence of structural abnormalities. However, symptoms 
and signs of early HF can be difficult to interpret among elderly with higher degrees 
of comorbidities and among obese patients. And the problem of defining heart failure 
can especially be seen in its milder forms where patients may complain of breathless-
ness, tiredness, and fatigue but without having echocardiographic evidence of left 
ventricular systolic dysfunction.2–3 The European Society of Cardiology (ESC) has 
developed guidelines for the diagnosis, assessment, and treatment of HF which to Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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some extent may have clarified the difficulties in diagnosing 
HF.1,2 However, there might still be some isolated patients 
with difficulties in heart failure classification.
Following the considerable health problem of HF there 
is a need for reliable methods for identification of patients 
with HF. Data on hospitalization due to HF are registered in 
hospital discharge registers with specific HF codes. These 
administrative registers are increasingly used in health research 
and provide important information on diagnosis-related group 
(DRG)-values and patient volume. However, due to the dif-
ficulties in diagnosing HF the accuracy of coding HF has been 
questioned.4–9 The aim of this study was therefore to estimate 
the positive predictive value (PPV) of recorded diagnoses of 
HF in a University Hospital discharge register against ESC 
guidelines, and to examine the impact of misdiagnosing HF.
Material and methods
Herlev University Hospital is serving a local population of 
200,000. The Danish National Registry of Patients (NRP) 
identified patients referred to the outpatient clinic (OPC), 
heart failure clinic (HFC), or those admitted to the cardiology 
ward in Herlev University Hospital and discharged with a HF 
diagnosis, during the period July 1, 2005 to June 30, 2007. This 
register contains 99.4% of all discharge records from Danish 
hospitals including outpatient visits, and information about the 
diagnoses has been coded according to the International Clas-
sification of Diseases, 10th edition (ICD-10).10 The codes used 
for identification of heart failure patients were: I11.0 (hyperten-
sive heart disease with heart failure), I13.0 (hypertensive heart 
and renal disease with heart failure), I13.2 (hypertensive heart 
and renal disease with both heart failure and renal disease), 
I42.0 (dilated cardiomyopathy), I42.6–9 (other cardiomyopa-
thies), I50.0–I50.1 and I50.9 (heart failure).
The authors systematically reviewed the records of all 
patients with a discharge diagnosis of heart failure during the 
period of October 14, 2009 to March 23, 2010. Author SM, 
who is following a clinical and research training programme 
in cardiology, initially reviewed the records. The recorded 
data were checked and transferred to a database by author FN, 
who is a specialist in cardiology. If the two authors disagreed 
about a HF diagnosis, the case was adjudicated by consensus 
agreement after discussion.
The following information was obtained from the records: 
age; gender; weight; height; tobacco use and alcohol consump-
tion; results of laboratory tests; the probability of heart failure, 
and if the registered heart failure diagnosis was a primary or 
secondary diagnosis, and if heart failure was new, onset or chronic 
heart failure; New York Heart Association class (NYHA); history 
of ischemic heart disease (IHD), ie, angina pectoris, previous 
myocardial infarction, previous performed percutanous coronary 
intervention (PCI) or coronary artery by-pass grafting (CABG); 
history of valve disease; other comorbidities, ie, chronic pulmo-
nary disease, hypertension, diabetes mellitus, stroke, atrial fibril-
lation, thyroid disease; and pacemaker or implantable cardioverter 
defibrillator unit implant. Diabetes mellitus was considered 
present if the patients were on antidiabetic therapy with diet or 
medication. Hypertension, chronic pulmonary lung disease, and 
thyroid disease were defined as a history of the specific diseases 
diagnosed by the patient’s doctor. Previous stroke was considered 
present if the diagnosis was confirmed from the records.
The 12-lead electrocardiogram (ECG) were reviewed and 
analyzed for rhythm (sinus rhythm, atrial fibrillation, other 
rhythms), bundle branch block, left ventricular hypertrophy 
(LVH), and ischemia. LVH was determined as the voltage sum 
SV1 + RV5 or RV6 $ 35 mm using Sokolow–Lyon voltage 
criteria, and myocardial ischemia was considered present if 
a $1 mm horizontal or downward sloping ST shift in .1 of 
the 12 electrocardiographic leads was found.
All echocardiographic descriptions were reviewed by the 
authors and information on dimensions of the left chambers, 
left ventricular ejection fraction (LVEF), and severity of valve 
diseases was registered. Information on pulmonary congestion 
was obtained from the descriptions of the chest X-ray.
Information was obtained from the records regarding 
medical treatment, referral to the HFC or the OPC after 
discharge, referrals for invasive examinations (coronary 
angiography) and invasive treatments (PCI, CABG, valve 
operation), and readmissions during the first years.
Inadequate information about some of the variables 
(eg, NYHA classification, chamber dimensions on echocardio-
grams, laboratory tests) excluded them from further analyses.
Data on survival were obtained from the Danish Civil 
Registration System. The study was registered and approved 
by the Danish Data Protection Agency.
Definition of heart failure
ESC guidelines for the diagnosis of heart failure, valid for the 
period under study, were used as diagnostic criteria.1 In accor-
dance with these criteria the patients should have the following 
symptoms of heart failure: typically breathlessness or fatigue, 
either at rest or during exertion, or ankle swelling, and objective 
evidence of cardiac dysfunction shown by echocardiography.
The records and referral notes from the patient’s general 
practitioner (GP) were reviewed carefully for description of 
symptoms and signs of heart failure on admission or at the 
time for referring from the GP.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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The probability of heart failure was graded in definite 
heart failure (DHF) and no heart failure (NHF). DHF was 
defined as symptoms and signs of heart failure with at least 
one objective evidence of a structural or functional abnormal-
ity of the heart. Patients with structural abnormalities of the 
heart on echocardiography but with doubts about symptoms 
and signs of HF were classified as having DHF.
Statistics
All patients were followed from the date of admission until 
death or end of follow-up, whichever came first. Continuous 
data were summarized as median, interquartile range (IQR), 
and range. Categorical variables were reported as frequen-
cies and percentages. Differences in baseline variables were 
estimated by use of absolute differences (DIF) with 95% 
confidence intervals (CI) for categorical variables or Wil-
coxon rank-sum test for continuous variables.
Survival was estimated by the Kaplan–Meier method. 
The non parametric log-rank procedure was used to compare 
survival times in groups. The proportional-hazards assump-
tion was evaluated graphically, with plots of logarithm of 
negative logarithm of survival.
The PPV was calculated as the proportion of patients 
registered with a HF diagnosis in the NRP and who also 
fulfilled the ESC criteria for HF.
Data were analyzed using Stata 11.0 (StataCorp, College 
Station, TX).
Results
During the study period, 758 patients were either hospitalized 
acute (60.0%) or referred to the OPC or HFC, and all had a 
discharge diagnosis of heart failure. A total of 320 (42.2%) 
of the patients were women. The median age was 75 years 
(interquartile range [IQR] 65–82; range 33–99).
Baseline characteristics according to the criteria of HF 
used are shown in Table 1. A total of 637 patients with a reg-
istered HF diagnosis in the NRP fulfilled the criteria of DHF 
(Table 1). The PPV of a HF discharge diagnosis was estimated 
to 84.0% (95% CI: 81.2–86.6). Among patients (n = 479) with 
first time HF the PPV were 77.9% (95% CI: 74.1–81.6).
Patients with DHF were older (P , 0.001) and were 
more often men (DIF 16.6%; 95% CI: 6.9–26.1); they more 
often had a history of ischemic heart disease (DIF 26.1%; 
95% CI: 16.8–34.8) and atrial fibrillation (DIF 28.6%; 
95% CI: 20.1–36.1), and their body mass index (BMI) 
was lower (P = 0.002). Patients with DHF were more often 
examined with ECG (DIF 6.1%; 95% CI: 1.4–11.8) and 
echocardiography (DIF 17.4; 95% CI: 10.2–25.4), and they 
more often showed signs of hypertrophy (DIF 9.6%; 95% 
CI: 2.3–15.7) and ischemia (DIF 28.7%; 95% CI: 19.0–37.6) 
on the ECG, and had a lower LVEF (P , 0.001). A greater 
proportion of HF patients were followed in the HFC or OPC 
(DIF 54.5%; 95% CI: 49.0–58.5). A greater proportion of 
patients with DHF were more often treated with ace-inhibi-
tors and angiotensine II receptor blockers (DIF 44.8%; 95% 
CI: 35.4–53.4), beta-blockers (DIF 38.6%; 95% CI: 29.4–
47.0), and spironolactone (DIF 26.9%; 95% CI: 20.5–31.9). 
Table 1 Characteristics of patients in relation to heart failure 
classification
DHF NHF
registered hF in the NrP (n) 637 121
Age, years 75.7 69.9
Male (%) 60.4 43.8
ihD (%) 55.9 29.8
BMi (kg/m2) 25.5 28.2
hypertension (%) 45.5 53.7
Diabetes (%) 18.7 16.5
COPD (%) 15.5 9.9
Atrial fibrillation (%) 47.6 19.0
ECg performed (%) 97.8 91.7
  sinus rhythm (%) 56.0 82.0
  Atrial fibrillation (%) 39.2 16.2
  hypertrophy (%) 20.4 10.8
  ischemia (%) 58.4 29.7
Echo performed (%) 95.1 77.7
  LVEF%; median 35 60
  Aortic stenosis
    Mild (%) 1.0 0
    Moderate (%) 1.7 0
    severe (%) 5.3 0
  Mitral valve regurgitation
    Mild (%) 36.8 15.4
    Moderate (%) 15.2 0
    severe (%) 4.2 0
  Tricuspid regurgitation 20.4 0
  ( $40 mmhg) (%)
Chest X-ray performed (%) 79.7 62.8
  Pulmonary congestion (%) 43.7 0
Creatinine (umol/L); median 106 106
Follow-up in hFC/OPC (%) 56.2 1.7
Medical treatment
  ACE-inhibitor/Aii-antagonist (%) 78.6 33.9
  Beta-blocker (%) 67.5 28.9
  spironolactone (%) 32.7 5.8
readmission (12 months)% 54.6 37.2
  hF (%) 13.8 0
  AMi (%) 3.5 0
  Angina pectoris (%) 5.0 3.3
  stroke (%) 2.7 1.7
  Atrial fibrillation (%) 2.7 2.5
Abbreviations:  ACE,  angiotensin-converting  enzyme;  AMi,  acute  myocardial 
infarction; BMi, body mass index; COPD, chronic obstructive pulmonary disease; 
ihD, ischemic heart disease; hF, heart failure; hFC, heart failure clinic; LVEF, left 
ventricular ejection fraction; OPC, outpatient clinic.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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Only a few of the NHF patients were readmitted to hospital 
during the 12 months period after discharge (Table 1).
The median follow-up time for survival was 2.9 years. 
Survival rate among patients with DHF was 0.41 (95% CI: 
0.36–0.46) compared to 0.61 (95% CI: 0.46–0.72) among 
NHF patients (P , 0.001) (Figure 1). Restriction of survival 
analysis to NHF patients depending on echocardiographic 
examinations revealed a significant lower survival rate of 0.41 
(95% CI: 0.21–0.60) among patients without echocardiog-
raphy compared to patients with echocardiography who had 
a survival rate of 0.66 (95% CI: 0.47–0.80) with a dramatic 
decline in survival during the initial phase of the follow-up 
period (Figure 2).
Discussion
We found a PPV of coding for HF among patients admitted 
to a University Hospital cardiac care unit of 84%. One study 
found a lower PPV (65.1%).8 However, several other studies 
found similar or higher PPV compared to our study.4–5,7–9 
Differences in validity of HF discharge diagnoses reflect the 
fact that HF is a complex syndrome with clinical criteria that 
are less clear-cut compared to other diagnoses.
Almost 15% of the patients were diagnosed in the NRP as 
having HF without fulfilling the ESC criteria for HF. About 
one quarter of the patients diagnosed in the NRP as having 
HF were not examined by echocardiography and did not 
have any objective signs of dysfunction of the heart. Since 
these patients did not completely meet the ESC criteria for 
HF we classified the patients as having NHF. Although these 
patients in the NRP were classified as having HF none of 
these patients were followed in the OPC or HFC, fewer were 
treated with HF medication, fewer were readmitted during 
the 12-month period after discharge and their survival rate 
was significantly higher. However, a stratified analysis of 
NRP-HF patients without ESC-HF divided in groups with and 
without echocardiography performed revealed a significant 
lower survival rate among patients without echocardiography 
compared to patients who were examined by echocardiogra-
phy. These findings indicate that the patients without echocar-
diography performed, were probably correctly classified as 
having HF although they did not have objective signs of 
cardiac dysfunction.
It was not possible to explore why some of the patients 
were not examined by an echocardiography. Symptoms and 
signs are important as they alert the observer to the possibility 
that heart failure exists. The clinical suspicion of heart failure 
must be confirmed by objective tests particularly aimed at 
assessing cardiac function and aetiology to HF and to direct 
treatment strategy. Confirmation by echocardiography of 
the diagnosis of HF is mandatory and should be performed 
shortly following suspicion of the diagnosis of HF.2 The 
rapid and dramatic decline in survival in the initial phase of 
the course among patients without echocardiography could 
indicate that some of the patients failed to get the examination 
due to early death. Whether the causes of death were related 
to cardiac disease or comorbidities is unknown.
Our findings may suggest that the use of hospital discharge 
registers might overestimate admissions for HF and the total 
burden of the disease. However, this study of admissions with 
hospitalization due to HF is only able to identify correctly coded 
cases and false-positive cases. We were not able to identify 
the false-negative cases in our department. A high specificity 
of the diagnosis of HF and low sensitivity values and signs 
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Figure 1 Kaplan–Meier plot of survival in patients with a discharge diagnosis of heart 
failure (hF) in accordance with criteria from the European society of Cardiology 
(ESC) and patients with a discharge diagnosis of heart failure but without fulfilling 
the EsC criteria for hF.
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Figure 2 Kaplan–Meier survival plot of patients classified as having no heart failure 
in relation to if echocardiography was performed.Clinical Epidemiology
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of underestimation of the diagnosis of HF in administrative 
registries has been found in other studies.5–9 Since the codes 
underreport the magnitude of HF, discharge coding for HF is not 
suitable for use in studies of prevalence and incidence of HF.5 
Our results have important implications. We found a 
relatively high PPV of the HF diagnosis in the NRP and the 
NRP can therefore be a valuable tool for identification of 
patients with HF. However, using the NRP alone will not give 
a true picture of the cost and total burden of the disease.
Certain limitations exist in this study of heart failure 
discharge diagnosis. First, our cohort was a group of patients 
admitted to a cardiac care unit. Others have shown variability 
in accuracy of a code for HF within different hospital depart-
ments, and therefore our results may not be representative 
for all patients admitted with suspicion of HF.5,7 Second, 
our study of a historic cohort is retrospective in nature and 
in some cases characterized by inadequate descriptions of 
symptoms and signs in the medical records. This might in 
some case have induced misclassification of the patients. 
Third, the echocardiographic examinations have mainly 
focussed on systolic cardiac function and valvular heart dis-
eases. Diastolic parameters were not measured routinely and 
it could not be excluded that some of the patients classified 
as having no HF might have suffered diastolic dysfunction 
and therefore were misclassified.
Conclusion
Medical registries such as NRP are important tools in 
epidemiological and clinical research. We found a relatively 
high predictive value and therefore NRP can be a valuable 
tool for identification of patients with HF. However, a rela-
tively large number of the patients were registered in the 
NRP as having HF without meeting the ESC criteria for HF. 
These patients were among others characterized by a better 
survival, a lower readmission rate, none were followed in the 
OPC, and they had a lower consumption of anticongestive 
medicine indicating that the NRP can not give a reliable 
picture of total burden and costs of the disease.
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